These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21589646)

  • 1. Evaluation of iron oxide nanoparticle biocompatibility.
    Hanini A; Schmitt A; Kacem K; Chau F; Ammar S; Gavard J
    Int J Nanomedicine; 2011; 6():787-94. PubMed ID: 21589646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced cellular uptake of aminosilane-coated superparamagnetic iron oxide nanoparticles in mammalian cell lines.
    Zhu XM; Wang YX; Leung KC; Lee SF; Zhao F; Wang DW; Lai JM; Wan C; Cheng CH; Ahuja AT
    Int J Nanomedicine; 2012; 7():953-64. PubMed ID: 22393292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging.
    Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I
    Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies.
    Wu W; Chen B; Cheng J; Wang J; Xu W; Liu L; Xia G; Wei H; Wang X; Yang M; Yang L; Zhang Y; Xu C; Li J
    Int J Nanomedicine; 2010 Dec; 5():1079-84. PubMed ID: 21170355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.
    Vakili-Ghartavol R; Momtazi-Borojeni AA; Vakili-Ghartavol Z; Aiyelabegan HT; Jaafari MR; Rezayat SM; Arbabi Bidgoli S
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):443-451. PubMed ID: 32024389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Block copolymer cross-linked nanoassemblies improve particle stability and biocompatibility of superparamagnetic iron oxide nanoparticles.
    Dan M; Scott DF; Hardy PA; Wydra RJ; Hilt JZ; Yokel RA; Bae Y
    Pharm Res; 2013 Feb; 30(2):552-61. PubMed ID: 23080062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration.
    Pham BTT; Colvin EK; Pham NTH; Kim BJ; Fuller ES; Moon EA; Barbey R; Yuen S; Rickman BH; Bryce NS; Bickley S; Tanudji M; Jones SK; Howell VM; Hawkett BS
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29320407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
    Silva LH; da Silva JR; Ferreira GA; Silva RC; Lima EC; Azevedo RB; Oliveira DM
    J Nanobiotechnology; 2016 Jul; 14(1):59. PubMed ID: 27431051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Assessment of Nano-Technologies for Cancer Treatment: Cytotoxicity and Hyperthermia Laboratory Studies.
    Medina-Ramírez IE; Díaz de León Olmos MA; Muñoz Ortega MH; Zapien JA; Betancourt I; Santoyo-Elvira N
    Cancer Invest; 2020 Jan; 38(1):61-84. PubMed ID: 31791151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flame synthesis and in vitro biocompatibility assessment of superparamagnetic iron oxide nanoparticles: cellular uptake, toxicity and proliferation studies.
    Buyukhatipoglu K; Miller TA; Clyne AM
    J Nanosci Nanotechnol; 2009 Dec; 9(12):6834-43. PubMed ID: 19908687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.
    Arami H; Khandhar A; Liggitt D; Krishnan KM
    Chem Soc Rev; 2015 Dec; 44(23):8576-607. PubMed ID: 26390044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic investigation of interaction of biocompatible iron oxide nanoparticles with epithelial cells for biomedical applications.
    Panariti A; Lettiero B; Alexandrescu R; Collini M; Sironi L; Chanana M; Morjan I; Wang D; Chirico G; Miserocchi G; Bucci C; Rivolta I
    J Biomed Nanotechnol; 2013 Sep; 9(9):1556-69. PubMed ID: 23980503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
    Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular magnetic response and biocompatibility of biogenic zinc- and cobalt-doped magnetite nanoparticles.
    Moise S; Céspedes E; Soukup D; Byrne JM; El Haj AJ; Telling ND
    Sci Rep; 2017 Jan; 7():39922. PubMed ID: 28045082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biocompatibility of Fe₃O₄@Au composite magnetic nanoparticles in vitro and in vivo.
    Li Y; Liu J; Zhong Y; Zhang J; Wang Z; Wang L; An Y; Lin M; Gao Z; Zhang D
    Int J Nanomedicine; 2011; 6():2805-19. PubMed ID: 22131827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro biocompatibility assessment of functionalized magnetite nanoparticles: biological and cytotoxicological effects.
    Mbeh DA; França R; Merhi Y; Zhang XF; Veres T; Sacher E; Yahia L
    J Biomed Mater Res A; 2012 Jun; 100(6):1637-46. PubMed ID: 22447386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.
    Cheng FY; Su CH; Yang YS; Yeh CS; Tsai CY; Wu CL; Wu MT; Shieh DB
    Biomaterials; 2005 Mar; 26(7):729-38. PubMed ID: 15350777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of magnetic nanoparticles containing Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin, a new generation choriocarcinoma-specific gene vector.
    Jingting C; Huining L; Yi Z
    Int J Nanomedicine; 2011; 6():285-94. PubMed ID: 21383853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics, tissue distribution and magnetic resonance's response characterstics of folic acid-O-carboxymethyl chitosan ultrasmall superparamagnetic iron oxide nanoparticles in mice and rats].
    Gao WH; Liu ST; Fan CX; Qi LY; Chen ZL
    Yao Xue Xue Bao; 2011 Jul; 46(7):845-51. PubMed ID: 22010356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrier.
    Hoff D; Sheikh L; Bhattacharya S; Nayar S; Webster TJ
    Int J Nanomedicine; 2013; 8():703-10. PubMed ID: 23426527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.